Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Drug Discovery & Development
Revealing and retrieving highly potent IFN-? secretors using an Xdrop® single-cell format workflow based on double-emulsion droplets
Bulk functional assays of immune cells miss highly potent cells within the population. This Xdrop single-cell format workflow for IFN-? secretion assessment reveals these highly potent individual cells, enabling their retrieval and expansion.
Drug Discovery & Development
Xdrop® Encapsulate cells, DNA, and more with this benchtop instrument
Xdrop is a unique, user-friendly microfluidics instrument for preparing living mammalian or microbial cells, organelles, DNA, or other biological material for high-resolution downstream analyses.
Stem Cell Therapy
Induced Pluripotent Stem Cells to be Manufactured on the ISS
With evidence suggesting that microgravity conditions may be best for growing and developing pluripotent stem cells, a team of astronauts aboard the International Space Station are set to test this hypothesis.
Antibody & Protein Engineering
Sony and Astellas Team Up to Create Breakthrough ADC Oncology Platform
Sony and Astellas join forces to develop an ADC platform that leverages Sony's Kiravia Backbone for enhanced drug delivery and stability.
Peptide Chemistry
Sustainable Medicines Partnership: A Pan Stakeholder Action Collaborative
A program to reduce the waste of medicines and waste from medicines, centred around six pillars for sustainable pharma.
Oligo Chemistry
Refractive Index Paves the Way to Greener Peptide and Oligonucleotide Synthesis
John Lopez of Novartis discusses the more sustainable possibilities refractive index monitoring offers in SPPS and SPOS.
Drug Discovery & Development
Cancer Vaccines: Analysing the Resurgence
Looking at the past, present, and future of cancer vaccines. What are the reasons for past failings? And what's the next step for their development?
Manufacturing & Bioprocessing
Crossing the Pond: Key Considerations for Stateside Biotechs Looking to the UK and Europe
Among the challenges faced by US biotechs looking at setting up in Europe, regulatory and cultural differences are chief among them. However, the strong tradition of scientific research and high standard of medical care across the Atlantic makes it worth the effort.
Biomarkers & Precision Medicine
A ‘New Age’ of Biomarker Technology? Understanding Identification & Validation of IO Biomarkers
Developing and validating IO biomarkers present challenges, such as working with challenging sample types, interpreting sequencing data, and integrating new technologies into the clinic.
Peptide Chemistry
Peptide Characterisation Methods and Impurity Detection
Key opinion leaders discuss techniques for peptide characterisation and the challenges posed by increasing regulatory requirements.
Immunotherapy (Non-Oncology)
Antibody Therapies to Get Boost from Genmab and Argenx Partnership for Immunology and Oncology
The partnership aims to address unmet patient needs in the areas of immunology and cancer.